‘Changing the whole game of drug discovery’: Legendary R&D vet Roger Perlmutter leaps back into work as a biotech CEO Portfolio News / By Karina Tin May 5, 2021
Eikon Therapeutics Closes $148 Million Series A Financing to Develop High-Throughput, Super-Resolution Microscopy for Drug Discovery Portfolio News / By Karina Tin May 5, 2021
Perlmutter named CEO of Eikon, a biotech with $148M to apply Nobel-winning tech to undruggable targets Portfolio News / By Karina Tin May 5, 2021
Carmot Therapeutics Announces Investigational New Drug (IND) Clearance for CT-868, a Dual GLP-1 and GIP Receptor Modulator for the Treatment of Overweight and Obese Patients with Type 2 Diabetes Portfolio News / By Karina Tin May 04, 2021
Escient Pharmaceuticals Names Svetlana Makhni As Chief Financial Officer Portfolio News / By Karina Tin May 3, 2021
Synthekine Appoints Internationally Recognized Cancer Immunotherapy Leader Naiyer Rizvi, M.D., as Chief Medical Officer Portfolio News / By Karina Tin May 3, 2021